Mechanisms of Disease: genetic causes of familial hypercholesterolemia

By A. Soutar, R. Naoumova. Nature Clinical Practice Cardiovascular Medicine, 2007

617 citations recorded by the source corpus.

Citations in the corpus

Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations (2016, neutral): “Diabetes mellitus is diagnosed based on fasting plasma glucose ≥126 mg/dL (7.0 mmol/L), 2-hour glucose after 75-g oral glucose load ≥200 mg/dL (11.1 mmol/L), hemoglobin A 1c (HbA 1c ) ≥6.5% (48 mmol/mol), or random plasma glucose ≥200 mg/dL confirmed by repeat testing in the absence of signs or symp”
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (2014, neutral): “Other sources of variability in the HoFH phenotype may arise from small effect genetic variants (common single nucleotide polymorphisms), gene–gene and gene–environment interactions, and non-Mendelian and epigenetic influences.(6,9,10) Greater access and wider clinical application of next generation”
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue (2019, neutral): “References [349–466]”